Zambia National Public Health Institute conducts Early Market Engagement for Construction and Equipping of Advanced Public Health Laboratory Complex 

0
FB_IMG_1771515171271

Group Picture

Wednesday, 18th February 2026 Press Statement

The Zambia National Public Health Institute (ZNPHI) conducted an Early Market Engagement (EME) with industry stakeholders ahead of the procurement process for the construction and equipping of a state-of-the-art Laboratory Complex in Chongwe.

The EME is an opportunity to exchange ideas, understand market capabilities, and refine the strategy before formal procurement begins. Today’s engagement forms part of the US$86 million Africa CDC Regional Investment Financing Project, which aims to strengthen continental and regional infectious disease detection and response systems.

ZNPHI Africa Centres for Disease Control and Prevention (Africa CDC) Regional Investment Financing Project (ACDCP) Project Coordinator, Dr Joseph Nikisi.

Speaking during the engagement, ZNPHI Africa Centres for Disease Control and Prevention (Africa CDC) Regional Investment Financing Project (ACDCP) Project Coordinator, Dr Joseph Nikisi said the initiative, supported through financing from the World Bank, is a continental effort designed to strengthen infectious disease detection and response systems across Africa.

(From right to left) Zambia National Public Health Institute Senior One Health Officer (Animal Health), Dr. Ricky Chazya, from the Ministry of Fisheries and Livestock, hands over rabies drugs to Chongwe Municipal Authority District Fisheries and Livestock Coordinator, Dr. Francis Mwanza, in Chongwe.

“The project represents more than infrastructure development; it reflects a strategic investment in preparedness, innovation, and collective action to safeguard populations against emerging health threats. Today’s session, therefore, represents an important milestone in our procurement journey. It provides an open platform to share information about the planned Construction and Equipping of the ZNPHI Laboratory Complex, including high-containment biosafety facilities (BSL3), while also allowing us to listen to industry insights that can strengthen our approach,” he said.

The upcoming procurement involves the construction and full equipping of a modern laboratory complex comprising Biosafety Level 1, 2, and 3 laboratories (BSL-1, BSL2, ACL-2, and BSL-3), administrative spaces, a Proficiency Testing Panel Production

Group Picture: Zambia National Public Health Institute (ZNPHI) conducted an Early Market Engagement (EME)

Centre, a Biomedical Equipment Maintenance Centre, as well as a Biobank and Nitrogen Plant. The tender is expected to be published in mid-2026.

Dr. Nikisi explained that EME is a key element of modern procurement under World Bank–financed operations with value more than USD 10 million. The procurement regulations emphasise that engagements with the market, such as meetings, workshops, or structured discussions with potential bidders, allow borrowers to understand industry capacity, refine technical requirements, and promote fair and transparent competition before formal bidding begins.

ZNPHI would like to thank the World Bank, Africa CDC, the Government of Zambia through the Ministry of Health, and all stakeholders whose continued support makes this vision possible. Together, we are laying the foundation for a stronger, more resilient public health system not only for Zambia, but for Africa as a whole.

About ZNPHI

The Zambia National Public Health Institute is a statutory body under the Ministry of Health responsible for disease surveillance, public health research, and emergency preparedness and response in Zambia.

For media inquiries, please contact:

Dr. Doreen Shempela,  

Director, Public Health Policy Diplomacy and Communications (PHPDC) Doreen.Shempela@znphi.gov.zm

Leave a Reply

Your email address will not be published. Required fields are marked *

You may have missed

绝妙集团公布50亿美元投资计划​作者:海伦·博瓦利亚(Hellen Bwalya)​绝妙集团有限公司(Wonderful Group of Companies Limited)通过其子公司赞比亚联合资本化肥有限公司(United Capital Fertilizer Zambia Company Limited),在其工业园区举行的奠基仪式上,正式启动了一项跨越2025年至2030年的50亿美元中长期工业投资宏伟计划。集团首席执行官黄耀弛先生在致答谢词时强调,该举措巩固了集团致力于提升赞比亚经济潜力、农业发展和就业水平的长期承诺。本次活动展示了多项价值数亿美元的制造业扩建及基础设施升级项目,旨在将赞比亚打造成中东非地区的核心工业强国。​在这项50亿美元的投资承诺中,园区内大规模的化工与化肥厂建设处于核心地位。继投资6.8亿美元的一期尿素生产厂竣工并投入运营后,集团正在稳步推进投资3.00亿美元的农化磷肥厂建设,预计将于第一季度投产,用于生产专用二铵(DAP)化肥。进一步的扩建计划还包括投资16亿美元的二期尿素项目和投资7.00亿美元的磷肥扩建项目,同时集团还将努力吸引更多绿色与高新技术投资者入驻运营。​为了支持这一工业增长并优化大宗运输物流,绝妙集团宣布了多项基础设施升级计划,包括升级连接当地矿山并穿过该工业园区的区域铁路网络、将蒙格维路(Mungwi Road)的部分路段改造为双向四车道,以及拓宽通往蒙布瓦路(Mumbwa Road)的连接线。这些基础设施项目将在完成内部财务手续后,通过政府与社会资本合作(PPP)模式实施,以畅通交通流量并缩短物资交付时间。黄耀弛先生对关键金融合作伙伴表达了谢意,向由艾莎银行(Absa Bank PLC)和赞比亚国家商业银行(ZANACO Bank PLC)牵头的银行银团为相关建设提供资金支持致以深切感谢。​在澄清公司身份时,黄耀弛先生指出,尽管早期外界存在误解,但绝妙集团和联合资本化肥公司均是值得骄傲的赞比亚本土企业。他强调,管理层中仅有两名中国籍员工,且均未直接参与日常运营,企业的行政控制权与管理权完全掌握在赞比亚本地人手中。黄耀弛先生重申了集团的承诺,并对赞比亚实现自产自销、对外出口以及引领东非和南部非洲工业未来的能力表达了坚定信心。